Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Arexela AB
AB
Active
Org 5569528721
Jakobshöjdsvägen 8
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2013
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,1M
-5% vs 2024
EBITDA margin
67.2%
+142% vs 2024
Equity ratio
74.0%
Financial strength
Net profit 2025
SEK 1,2M
+25% vs 2024
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
2M
2021
2M
0%
2022
2M
0%
2023
1M
-50%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 2,1M
-5%
EBITDA
SEK 1,4M
+142%
Net profit
SEK 1,2M
+25%
Total assets
SEK 13,8M
+7%
Equity
SEK 10,2M
+10%
Employees
0
—
Company information
Legal name
Arexela AB
Org number
5569528721
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
10 december 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom läkemedelsforskning, utveckling och utbildning.
Contact
Address
Jakobshöjdsvägen 8
Email
margit.mahlapuu@gu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2021
3M
2022
3M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
2M
2021
2M
2022
2M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
2 712
2 911
2 822
2 250
2 138
Staff expenses
—
—
—
—
−7
EBITDA
2 221
2 371
2 338
593
1 436
Depreciation & amort.
−3
−0
−0
—
—
EBIT
2 218
2 371
2 338
593
1 436
Net financials
—
−1
1
586
64
Profit before tax
1 784
2 016
1 725
1 151
1 546
Tax
−395
−441
−380
−200
−355
Net profit
1 389
1 575
1 345
950
1 192
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
8 620
10 417
12 131
12 879
13 807
Equity
5 968
7 353
8 508
9 258
10 213
Long-term debt
0
0
0
—
—
Short-term debt
168
226
171
141
160
Total debt
168
226
171
141
160
Financial ratios
5-year trend
EBITDA margin
67.2%
This company
15.8%
Market median
+325% vs market
2021
2025
Equity ratio
74.0%
This company
38.2%
Market median
+94% vs market
2021
2025
Return on equity
11.7%
This company
18.4%
Market median
+36% vs market
2021
2025
Net profit margin
55.7%
This company
8.1%
Market median
+588% vs market
2021
2025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
2021
2025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-11-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MM
Margit Mahlapuu
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
LN
Lars Niklas Falkmer
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Arexela AB also hold positions in
0
other companies.
Person
Role here
Other companies
Margit Mahlapuu
Chief Executive Officer
0 companies
Lars Niklas Falkmer
Deputy Board Member
0 companies